https://www.selleckchem.com/products/azd5305.html
075, P less then 0.001) and costs (¥46 073 (36 837, 52 448) vs ¥130 798 (104 048, 186 188), Z=-10.059, P less then 0.001) were significantly less in TC group. After risk adjustment, there was no significant difference in 30 days survival between TC group and SC group. At a median follow-up of 21 months, there was a trend towards reduced all-cause death following TC versus SC (OR = 0.054, 95%CI 0.07 to 0.445, P= 0.007). Conclusions SC for PVL is associated with higher technical rates and less residual shunt compared with TC approach. But
Like
Comment
Share
